Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help scientists better predict how COVID-19 will evolve.
Atsena prioritizes retinal gene therapy pipeline, trims staff as existing investors refuel the biotech
Atsena Therapeutics has reduced its staff, is looking for a partner and has reeled in more cash from existing investors, the gene therapy biotech told